The telehealth Software market is projected to expand its roots at a strong CAGR of 15.7% during the forecast period. The market is likely to hold a revenue of US$ 6.85 billion in 2023 while it is anticipated to cross a value of US$ 29.56 billion by 2033.
The growing adoption of various telehealth software such as real-time communication software, store and forward telehealth software, and remote patient monitoring telehealth software is driving the demand for the telehealth software market.
The growing adoption of mobile wireless technologies and mHealth solutions for public health is spurring global demand. Integration of advanced technologies such as Artificial Intelligence (AI) and Machine Learning, the Internet of Medical Things (IoMT), smart health devices, and Big Data in telehealth software boosts the market growth.
| Attributes | Details |
|---|---|
| Telehealth Software Market CAGR (2023 to 2033) | 15.7% |
| Telehealth Software Market Size (2023) | US$ 6.85 billion |
| Telehealth Software Market Size (2033) | US$ 29.56 billion |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The telehealth software market demand is estimated to rise at 15.7% CAGR between 2023 and 2033 in comparison with the 13.8% CAGR registered from 2018 to 2022. The global telehealth software market is anticipated to witness an increase in revenue from US$ 6.85 billion in 2022 to US$ 29.56 billion by 2030.
Future Market Insights identifies North America, followed by Europe, as the leading market. Expansion in North America is supported by the region’s developed infrastructure and the large presence of telehealth software providers in the United States. Telehealth software is a simple platform that is used by providers to connect with patients remotely and shares video and images and consult for healthcare services.
Telehealth software integrates with scheduling systems and providers’ electronic health records (EHR). It gives physicians a secure and organized system for:
Growing adoption of advanced technology such as AI and Big data analytics in telehealth software is driving the global demand. Big data helps to process data which is collected from telehealth modalities such as subjective data (symptoms and patient behavior) and objective (vital signs and ambient environment) along with historical data. It enables risk management and prediction. AI and machine learning creates significant potential in the telehealth software market. Telehealth and telemedicine improve:
Due to such advantages, the demand for the telehealth software market has increased over the years.
Principal Consultant
| Countries | Revenue Share % (2022) |
|---|---|
| The United States | 21.3% |
| Germany | 8.7% |
| Japan | 5.4% |
| Australia | 4.1% |
| North America | 37.2% |
| Europe | 24.3% |
| Countries | CAGR % (2023 to 2033) |
|---|---|
| China | 16.2% |
| India | 17.2% |
| The United Kingdom | 15.2% |
The market in the United States is anticipated to be valued at around US$ 3.85 billion by 2030. The country might expand at a CAGR of 12.9% from 2023 to 2033. The market holds a market share of 21.3% in 2023 while North America held the leading share of 37.2% in 2022.
The United States is one of the prominent countries in telehealth software solutions sales. As per the United States CDC, chronic diseases such as cancer, heart disease, and diabetes are the leading causes of disability and death in the United States. It leads to US$ 3.8 trillion in annual healthcare costs. Thus, the increasing prevalence of chronic conditions, increase in healthcare expenditure of the country, and increasing geriatric population spur the demand for the telehealth software market.
The market for telehealth software in Germany held a value of around US$ 1.01 billion in 2022. Germany’s telehealth software market held a market share of 8.7% in 2022 while Europe itself held a share of 24.3% in the same year.
Germany witnessed developed infrastructure for the healthcare industry due to the increasing penetration of smart technologies such as AI, ML, and AR/VR across the healthcare sector. According to the international trade administration, Germany’s medical device market is expected to show significant growth worldwide accounting for roughly US$ 35.8 billion annually, and 25.6% of the total Europe market. Thus, such development in Germany’s healthcare sector is ultimately propelling the demand for the telehealth software market.
As per FMI, overall telehealth software spending in India is likely to increase at a rate of almost 17.2% from 2023 to 2033. It held a market value of around US$ 780.2 million in 2022.
As per IBEF, India’s healthcare market increased three-fold to US$ 133.44 billion in 2022 and public expenditure by the government on the healthcare sector stood at 1.2% of the total GDP. Therefore, such development and government initiatives toward the healthcare sector are expected to drive the demand for the telehealth software market in India.
| Category | By Component Type |
|---|---|
| Leading Segment | Software |
| Market Share (2022) | 58.7% |
| Category | By Deployment Type |
|---|---|
| Leading Segment | On-Premises |
| Market Share (2022) | 57.6% |
By component, the software segment is expected to expand 2.2X by 2033 and is expected to register a leading CAGR of 16.2% from 2023 to 2033. The segment held a notable market share of 58.7% in 2022. Telehealth software is used for:
The rising adoption of telehealth software by many healthcare providers is augmenting the demand for the telehealth software market.
As per FMI, by deployment, the on-premise segment showcased a leading market share of around 57.6% in 2022. Moreover, the cloud-based segment is set to expand at a high CAGR of 17.1% from 2023 to 2033.
On-premise telehealth software provides several advantages such as timely delivery of patient information, accurate patient information, better professional satisfaction, and efficient treatment of many patients at any given time. Moreover, the adoption of cloud services across the globe has increased in recent years, thus the demand for cloud-based telehealth software services is expected to increase during the forecasted period.
By end-user, the healthcare providers segment showcased an impressive market share of 58.0% in 2021 and it is set to expand at a high CAGR of 18.5% between 2023 and 2033.
Telehealth software helps healthcare providers reduce costs, and raise productivity, and profitability in healthcare practice. It also offers convenience and quality care to patients. It provides additional functions such as data security, a multi-platform approach, registration and patient profile, mobile payment, and others. Owing to such advantages, the demand for telehealth software among healthcare providers is boosting.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Telehealth Software providers are continuously focusing on cost reduction of the product and improved service for the consumer by implementing different strategies. The companies try to improve the quality of logistics operations and responsiveness to personalize customer service and increase the efficiency of their logistics and warehousing operations.
Market Developments:
The 2023 market value is US$ 6.85 billion.
The market will flourish at a 15.7% CAGR through 2033.
Europe holds a 21.3% revenue share in the market.
Key players are Aerotel Medical System, Koninklijke Phillips NV and Teladoc Inc.
The market will reach US$ 29.56 billion in 2033.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Component 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Component, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Component, 2023 to 2033 5.3.1. Software 5.3.1.1. Real Time Communication Software 5.3.1.2. Store and Forward 5.3.1.3. Remote Patient Monitoring 5.3.2. Services 5.3.2.1. Managed Services 5.3.2.2. Professional Services 5.4. Y-o-Y Growth Trend Analysis By Component, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Component, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Deployment 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Deployment, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Deployment, 2023 to 2033 6.3.1. Cloud-based 6.3.2. On-Premises 6.4. Y-o-Y Growth Trend Analysis By Deployment, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Deployment, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis By End User , 2018 to 2022 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User , 2023 to 2033 7.3.1. Healthcare providers 7.3.2. Healthcare payers and Patients 7.4. Y-o-Y Growth Trend Analysis By End User , 2018 to 2022 7.5. Absolute $ Opportunity Analysis By End User , 2023 to 2033 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022 8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033 8.3.1. North America 8.3.2. Latin America 8.3.3. Europe 8.3.4. South Asia 8.3.5. East Asia 8.3.6. Oceania 8.3.7. MEA 8.4. Market Attractiveness Analysis By Region 9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. The USA 9.2.1.2. Canada 9.2.2. By Component 9.2.3. By Deployment 9.2.4. By End User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Component 9.3.3. By Deployment 9.3.4. By End User 9.4. Key Takeaways 10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Component 10.2.3. By Deployment 10.2.4. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Component 10.3.3. By Deployment 10.3.4. By End User 10.4. Key Takeaways 11. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. United Kingdom 11.2.1.3. France 11.2.1.4. Spain 11.2.1.5. Italy 11.2.1.6. Rest of Europe 11.2.2. By Component 11.2.3. By Deployment 11.2.4. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Component 11.3.3. By Deployment 11.3.4. By End User 11.4. Key Takeaways 12. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. India 12.2.1.2. Malaysia 12.2.1.3. Singapore 12.2.1.4. Thailand 12.2.1.5. Rest of South Asia 12.2.2. By Component 12.2.3. By Deployment 12.2.4. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Component 12.3.3. By Deployment 12.3.4. By End User 12.4. Key Takeaways 13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. China 13.2.1.2. Japan 13.2.1.3. South Korea 13.2.2. By Component 13.2.3. By Deployment 13.2.4. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Component 13.3.3. By Deployment 13.3.4. By End User 13.4. Key Takeaways 14. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. Australia 14.2.1.2. New Zealand 14.2.2. By Component 14.2.3. By Deployment 14.2.4. By End User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Component 14.3.3. By Deployment 14.3.4. By End User 14.4. Key Takeaways 15. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 15.2.1. By Country 15.2.1.1. GCC Countries 15.2.1.2. South Africa 15.2.1.3. Israel 15.2.1.4. Rest of MEA 15.2.2. By Component 15.2.3. By Deployment 15.2.4. By End User 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Component 15.3.3. By Deployment 15.3.4. By End User 15.4. Key Takeaways 16. Key Countries Market Analysis 16.1. USA 16.1.1. Pricing Analysis 16.1.2. Market Share Analysis, 2022 16.1.2.1. By Component 16.1.2.2. By Deployment 16.1.2.3. By End User 16.2. Canada 16.2.1. Pricing Analysis 16.2.2. Market Share Analysis, 2022 16.2.2.1. By Component 16.2.2.2. By Deployment 16.2.2.3. By End User 16.3. Brazil 16.3.1. Pricing Analysis 16.3.2. Market Share Analysis, 2022 16.3.2.1. By Component 16.3.2.2. By Deployment 16.3.2.3. By End User 16.4. Mexico 16.4.1. Pricing Analysis 16.4.2. Market Share Analysis, 2022 16.4.2.1. By Component 16.4.2.2. By Deployment 16.4.2.3. By End User 16.5. Germany 16.5.1. Pricing Analysis 16.5.2. Market Share Analysis, 2022 16.5.2.1. By Component 16.5.2.2. By Deployment 16.5.2.3. By End User 16.6. United Kingdom 16.6.1. Pricing Analysis 16.6.2. Market Share Analysis, 2022 16.6.2.1. By Component 16.6.2.2. By Deployment 16.6.2.3. By End User 16.7. France 16.7.1. Pricing Analysis 16.7.2. Market Share Analysis, 2022 16.7.2.1. By Component 16.7.2.2. By Deployment 16.7.2.3. By End User 16.8. Spain 16.8.1. Pricing Analysis 16.8.2. Market Share Analysis, 2022 16.8.2.1. By Component 16.8.2.2. By Deployment 16.8.2.3. By End User 16.9. Italy 16.9.1. Pricing Analysis 16.9.2. Market Share Analysis, 2022 16.9.2.1. By Component 16.9.2.2. By Deployment 16.9.2.3. By End User 16.10. India 16.10.1. Pricing Analysis 16.10.2. Market Share Analysis, 2022 16.10.2.1. By Component 16.10.2.2. By Deployment 16.10.2.3. By End User 16.11. Malaysia 16.11.1. Pricing Analysis 16.11.2. Market Share Analysis, 2022 16.11.2.1. By Component 16.11.2.2. By Deployment 16.11.2.3. By End User 16.12. Singapore 16.12.1. Pricing Analysis 16.12.2. Market Share Analysis, 2022 16.12.2.1. By Component 16.12.2.2. By Deployment 16.12.2.3. By End User 16.13. Thailand 16.13.1. Pricing Analysis 16.13.2. Market Share Analysis, 2022 16.13.2.1. By Component 16.13.2.2. By Deployment 16.13.2.3. By End User 16.14. China 16.14.1. Pricing Analysis 16.14.2. Market Share Analysis, 2022 16.14.2.1. By Component 16.14.2.2. By Deployment 16.14.2.3. By End User 16.15. Japan 16.15.1. Pricing Analysis 16.15.2. Market Share Analysis, 2022 16.15.2.1. By Component 16.15.2.2. By Deployment 16.15.2.3. By End User 16.16. South Korea 16.16.1. Pricing Analysis 16.16.2. Market Share Analysis, 2022 16.16.2.1. By Component 16.16.2.2. By Deployment 16.16.2.3. By End User 16.17. Australia 16.17.1. Pricing Analysis 16.17.2. Market Share Analysis, 2022 16.17.2.1. By Component 16.17.2.2. By Deployment 16.17.2.3. By End User 16.18. New Zealand 16.18.1. Pricing Analysis 16.18.2. Market Share Analysis, 2022 16.18.2.1. By Component 16.18.2.2. By Deployment 16.18.2.3. By End User 16.19. GCC Countries 16.19.1. Pricing Analysis 16.19.2. Market Share Analysis, 2022 16.19.2.1. By Component 16.19.2.2. By Deployment 16.19.2.3. By End User 16.20. South Africa 16.20.1. Pricing Analysis 16.20.2. Market Share Analysis, 2022 16.20.2.1. By Component 16.20.2.2. By Deployment 16.20.2.3. By End User 16.21. Israel 16.21.1. Pricing Analysis 16.21.2. Market Share Analysis, 2022 16.21.2.1. By Component 16.21.2.2. By Deployment 16.21.2.3. By End User 17. Market Structure Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Market Share Analysis of Top Players 17.3.1. By Regional 17.3.2. By Component 17.3.3. By Deployment 17.3.4. By End User 18. Competition Analysis 18.1. Competition Deep Dive 18.1.1. Aerotel Medical System 18.1.1.1. Overview 18.1.1.2. Product Portfolio 18.1.1.3. Profitability by Market Segments 18.1.1.4. Sales Footprint 18.1.1.5. Strategy Overview 18.1.1.5.1. Marketing Strategy 18.1.2. Koninklijke phillips NV 18.1.2.1. Overview 18.1.2.2. Product Portfolio 18.1.2.3. Profitability by Market Segments 18.1.2.4. Sales Footprint 18.1.2.5. Strategy Overview 18.1.2.5.1. Marketing Strategy 18.1.3. Teladoc Inc. 18.1.3.1. Overview 18.1.3.2. Product Portfolio 18.1.3.3. Profitability by Market Segments 18.1.3.4. Sales Footprint 18.1.3.5. Strategy Overview 18.1.3.5.1. Marketing Strategy 18.1.4. American Well 18.1.4.1. Overview 18.1.4.2. Product Portfolio 18.1.4.3. Profitability by Market Segments 18.1.4.4. Sales Footprint 18.1.4.5. Strategy Overview 18.1.4.5.1. Marketing Strategy 18.1.5. Chiron health 18.1.5.1. Overview 18.1.5.2. Product Portfolio 18.1.5.3. Profitability by Market Segments 18.1.5.4. Sales Footprint 18.1.5.5. Strategy Overview 18.1.5.5.1. Marketing Strategy 18.1.6. Medtronic 18.1.6.1. Overview 18.1.6.2. Product Portfolio 18.1.6.3. Profitability by Market Segments 18.1.6.4. Sales Footprint 18.1.6.5. Strategy Overview 18.1.6.5.1. Marketing Strategy 18.1.7. Honeywell International 18.1.7.1. Overview 18.1.7.2. Product Portfolio 18.1.7.3. Profitability by Market Segments 18.1.7.4. Sales Footprint 18.1.7.5. Strategy Overview 18.1.7.5.1. Marketing Strategy 18.1.8. Tunstall healthcare 18.1.8.1. Overview 18.1.8.2. Product Portfolio 18.1.8.3. Profitability by Market Segments 18.1.8.4. Sales Footprint 18.1.8.5. Strategy Overview 18.1.8.5.1. Marketing Strategy 18.1.9. AMD Global Telemedicine 18.1.9.1. Overview 18.1.9.2. Product Portfolio 18.1.9.3. Profitability by Market Segments 18.1.9.4. Sales Footprint 18.1.9.5. Strategy Overview 18.1.9.5.1. Marketing Strategy 18.1.10. Cisco System 18.1.10.1. Overview 18.1.10.2. Product Portfolio 18.1.10.3. Profitability by Market Segments 18.1.10.4. Sales Footprint 18.1.10.5. Strategy Overview 18.1.10.5.1. Marketing Strategy 18.1.11. Medvivo group 18.1.11.1. Overview 18.1.11.2. Product Portfolio 18.1.11.3. Profitability by Market Segments 18.1.11.4. Sales Footprint 18.1.11.5. Strategy Overview 18.1.11.5.1. Marketing Strategy 18.1.12. Global Media Group 18.1.12.1. Overview 18.1.12.2. Product Portfolio 18.1.12.3. Profitability by Market Segments 18.1.12.4. Sales Footprint 18.1.12.5. Strategy Overview 18.1.12.5.1. Marketing Strategy 18.1.13. Cerner Corporation 18.1.13.1. Overview 18.1.13.2. Product Portfolio 18.1.13.3. Profitability by Market Segments 18.1.13.4. Sales Footprint 18.1.13.5. Strategy Overview 18.1.13.5.1. Marketing Strategy 18.1.14. Care Innovation 18.1.14.1. Overview 18.1.14.2. Product Portfolio 18.1.14.3. Profitability by Market Segments 18.1.14.4. Sales Footprint 18.1.14.5. Strategy Overview 18.1.14.5.1. Marketing Strategy 19. Assumptions & Acronyms Used 20. Research Methodology
Explore Technology Insights
View Reports
Telehealth Software Market
